Oral Sleep Apnea Devices Market Report 2025

The oral sleep apnea devices market size has grown rapidly in recent years. It will grow from $1.29 billion in 2024 to $1.46 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historical period can be attributed to heightened awareness of sleep disorders, a rising prevalence of obstructive sleep apnea, an increasing preference for noninvasive treatments, the expansion of sleep clinics and diagnostic centers, and greater adoption of oral appliances compared to continuous positive airway pressure machines.

The oral sleep apnea devices market size is expected to see rapid growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The projected growth in the forecast period can be attributed to rising demand for home-based sleep apnea solutions, increased emphasis on personalized oral devices, a growing elderly population with sleep-related conditions, the expansion of dental sleep medicine practices, and higher healthcare spending in emerging economies. Key trends expected during this time include advancements in digital dental scanning technology, ongoing research and development in oral appliance design, integration of smart sensors into oral devices, continuous innovation in lightweight and durable materials, and the development of 3D-printed custom oral devices.

The increasing prevalence of sleep disorders is expected to drive growth in the oral sleep apnea devices market in the coming years. Sleep disorders are medical conditions that disrupt normal sleep patterns, affecting the quality, timing, or duration of sleep. Rising stress levels contribute to the growing occurrence of sleep disorders by interfering with sleep, causing difficulties in falling asleep and poor rest overall. Oral sleep apnea devices help manage these disorders by keeping the airway open during sleep, reducing interruptions in breathing, and enhancing sleep quality. For example, in December 2023, SleepFoundation, a U.S.-based sleep health information company, reported that 37% of American adults experienced worse sleep in 2023 compared to the previous year. Hence, the rising prevalence of sleep disorders is boosting the oral sleep apnea devices market.

Leading companies in the oral sleep apnea devices market are developing portable devices featuring replaceable nylon connectors that allow precise mandibular adjustments, offering patients customizable, comfortable, and effective treatments. Replaceable nylon connectors are adjustable components that can be exchanged to finely control the forward positioning of the lower jaw for tailored therapy. For instance, in May 2024, James R. Glidewell Dental Ceramics, Inc., a U.S.-based dental laboratory and technology company, launched the Silent Nite 3D Sleep Appliance. This digitally fabricated, 3D-printed mandibular advancement device treats snoring and mild to moderate obstructive sleep apnea. It includes replaceable nylon connectors that permit mandibular adjustments in 0.5 mm increments, enhancing comfort and personalization. Additionally, its scalloped edge design improves retention while minimizing gum contact for greater user comfort.

In September 2023, Open Airway Dental Solutions Ltd., a Canada-based medical device company, acquired Oventus Medical Ltd. for $0.327 million. This acquisition granted Open Airway Dental Solutions Ltd. (OADS) ownership of Oventus Medical’s intellectual property and product portfolio, allowing it to expand its global presence in oral sleep apnea devices and better support sleep patients and healthcare professionals. Oventus Medical Ltd. is an Australia-based medical device manufacturer specializing in oral appliances for sleep apnea and snoring treatment.

Major players in the oral sleep apnea devices market are ResMed Inc., James R. Glidewell Dental Ceramics Inc., Fisher & Paykel Healthcare Limited, SomnoMed Limited, ProSomnus Sleep Technologies Inc., DynaFlex, Vivos Therapeutics Inc., Signifier Medical Technologies Ltd., Myerson LLC, Panthera Dental Inc., Braebon Medical Corporation, Apnea Sciences Corporation, MPowrx Health and Wellness Products 1 Inc., PureSleep Company, Somnics Health Co. Ltd., OravanOSA LLC, EMA Sleep, Alliance Sleep Corporation, OSAWELL Co. Ltd., Comprehensive Sleep Solutions LLC, and The Snore Reliever Company LLC.

North America was the largest region in the oral sleep apnea devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oral sleep apnea devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oral sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral sleep apnea devices market consists of sales of custom-fitted dental trays, adjustment mechanisms, retention systems, breathable and biocompatible materials, and embedded smart sensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The oral sleep apnea devices market research report is one of a series of new reports that provides oral sleep apnea devices market statistics, including the oral sleep apnea devices industry global market size, regional shares, competitors with the oral sleep apnea devices market share, detailed oral sleep apnea devices market segments, market trends, and opportunities, and any further data you may need to thrive in the oral sleep apnea devices industry. This oral sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Oral sleep apnea devices are custom-fitted dental appliances worn during sleep to maintain an open airway by repositioning the lower jaw or tongue. These devices are typically used to treat mild to moderate obstructive sleep apnea by preventing airway collapse, enhancing airflow, and reducing snoring, offering an alternative to bulky machines or surgery.

The main types of oral sleep apnea devices include mandibular advancement devices, tongue-retaining devices, rapid maxillary expansion appliances, and mouth guards. Mandibular advancement devices work by moving the lower jaw forward to keep the airway open during sleep and alleviate obstructive sleep apnea. They are indicated for mild, moderate, and severe sleep apnea cases. Distribution channels include brick-and-mortar stores, e-commerce platforms, and hospital pharmacies, with end users ranging from homecare settings to sleep laboratories, hospitals, and dental clinics.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.